Gastric Adenocarcinoma

general

An adenocarcinoma arising from the stomach glandular epithelium. Gastric adenocarcinoma is primarily a disease of older individuals. It most commonly develops after a long period of atrophic gastritis and is strongly associated with Helicobacter pylori infection. The lack of early symptoms often delays the diagnosis of gastric cancer. The majority of patients present with advanced tumors which have poor rates of curability. Microscopically, two important histologic types of gastric adenocarcino

76

Centers

148

Active Trials

$4.3B

Cancer Funding

Specific Cancer Types(1)

NameCenters
Unresectable Gastric Adenocarcinoma60

Top Centers for Gastric Adenocarcinoma(76)

Ranked by research excellence score (trials · grants · publications). Methodology →

#CenterScore
1
NCI Comprehensive
High-Volume Research Center
93.1
2
NCI Comprehensive
High-Volume Research Center
89.9
3
NCI Comprehensive
High-Volume Research Center
88.5
4
NCI Comprehensive
High-Volume Research Center
78.2
5
NCI Comprehensive
High-Volume Research Center
77.0
6
NCI Comprehensive
High-Volume Research Center
75.1
7
NCI Comprehensive
High-Volume Research Center
72.8
8
NCI Comprehensive
High-Volume Research Center
70.8
9
Active Research Program
67.8
10
NCI Comprehensive
Active Research Program
64.5
11
NCI Comprehensive
Active Research Program
62.6
12
Active Research Program
61.3
13
NCI Comprehensive
Active Research Program
61.2
14
Rutgers Cancer InstituteNew Brunswick, NJ
NCI Comprehensive
Active Research Program
59.8
15
NCI Comprehensive
Active Research Program
58.5
16
Active Research Program
58.2
17
Active Research Program
56.5
18
NCI Comprehensive
Active Research Program
56.0
19
Active Research Program
55.3
20
Active Research Program
54.5
21
Active Research Program
54.5
22
NCI Comprehensive
Active Research Program
54.3
23
NCI Comprehensive
Active Research Program
53.3
24
NCI Clinical
Active Research Program
53.0
25
NCI Comprehensive
Active Research Program
52.7
26
NCI Comprehensive
Active Research Program
51.7
27
NCI Comprehensive
Active Research Program
51.3
28
NCI Comprehensive
Active Research Program
50.3
29
NCI Comprehensive
Active Research Program
49.0
30
Active Research Program
48.0
31
NCI Comprehensive
Active Research Program
47.3
32
NCI Comprehensive
Active Research Program
47.0
33
Active Research Program
46.7
34
NCI Comprehensive
Active Research Program
46.3
35
NCI Comprehensive
Active Research Program
45.8
36
NCI Clinical
Active Research Program
45.7
37
NCI Comprehensive
Active Research Program
45.0
38
Active Research Program
44.0
39
NCI Comprehensive
Active Research Program
43.4
40
NCI Comprehensive
Active Research Program
42.1
41
NCI Comprehensive
Active Research Program
41.8
42
Fox Chase Cancer CenterPhiladelphia, PA
NCI Comprehensive
Active Research Program
41.4
43
NCI Comprehensive
Active Research Program
41.1
44
NCI Comprehensive
Active Research Program
40.8
45
NCI Comprehensive
Active Research Program
40.4
4640.1
47
NCI Comprehensive
Active Research Program
39.8
48
NCI Comprehensive
Active Research Program
39.4
49
NCI Clinical
Active Research Program
39.1
50
NCI Comprehensive
Active Research Program
37.4
51
Stephenson Cancer CenterOklahoma City, OK
NCI Clinical
Active Research Program
36.1
52
NCI Comprehensive
Active Research Program
35.8
53
Cedars-Sinai CancerLos Angeles, CA
Contributing Research Center
34.8
54
NCI Clinical
Contributing Research Center
32.8
55
NCI Comprehensive
Contributing Research Center
32.4
56
NCI Comprehensive
Contributing Research Center
31.4
57
Contributing Research Center
31.1
58
Contributing Research Center
28.1
5926.8
6026.8
61
62
NCI Comprehensive
63
NCI Comprehensive
64
65
66
67
Masonic Cancer CenterMinneapolis, MN
NCI Comprehensive
68
69
NCI Clinical
70
71
72
73
74
75
76

Research tier badges reflect trial volume, NIH grant funding, and publication impact — not clinical outcomes or patient satisfaction. Learn about our methodology →